Endeavor

Nearly 40 Percent of CAR T Patients Remain in Remission

Many ZUMA-1 participants remain in remission and more than half of those treated remain alive.

New Study Shows CAR T-cell Therapy for Lymphoma Lives up to its Press

Seventeen cancer centers compare real world outcomes of diffuse large B cell lymphoma patients treated with Yescarta® to ZUMA-1 clinical trial data

Can Chemo Cause Cognitive Decline in Older Patients?

A new study shows risk may be higher for those who carry Alzheimer’s gene.

Breast Cancer Survivors Find Their Wings in SOAR Program

“I learned that this isn’t temporary; survivorship is a lifestyle change...And that it’s all doable.”

How Old is Too Old for Chemotherapy?

Half of all cancers occur in people age 70 and older. We hear a lot of things about chemotherapy in older age. Which are myths and which are true?

What’s New in Breast Cancer Research?

Learn what Moffitt is doing bring new therapies to patients

Five Things to Know about Bone Marrow Donation

Only 30 percent of patients who need a bone marrow transplant have a genetic match in their family. That is why bone marrow registries like Be The Match and Gift of Life are so important.

Moffitt Uses Innovative Immunotherapy to Stand Up To (Lung) Cancer

The unique clinical trial combining two immunotherapies is funding by the Stand Up To Cancer Catalyst® Program.

Generous Donation Gives Breast Cancer Patients a Chance to Undergo Chemotherapy without Losing their Hair

Patient presented a check to Moffitt Cancer Center for more than $8,000, so other breast cancer patients can benefit from the DigniCap.